– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirmed QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Review – U.S. FDA Granted Fast Track Designation to QRX003 lotion (4%) for the treatment of Netherton Syndrome, Complementing Previously Granted Orphan Drug and Rare Pediatric Disease Designations – Constructive Type C Meeting with FDA: Single Phase 3 Study May Be Sufficient to Support U.S. Marketing Approval; FDA Open to Trial Design Without Traditional Vehicle or Placebo Control – Rare Pediatric Disease Priority Review Voucher Program Extended by Congress Through September 30, 2029 – On Track to Complete Phase 3 Patient Recruitment by End of 2026, with Potential NDA...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new Substance of Matter (SOM) patent covering two established compounds within the cystic fibrosis market. Sarborg announced that the patent was developed using its proprietary Signature Agent and Multi-Agent platform, supported by its Sarborg 1,600 Disease Database and Sarborg 1,700 Rare Disease Database. According to Sarborg, this approach enables rapid identification of new therapeutic opportunities, including additional indications and combination strategies, with patent filing achieved in less than three weeks. CDT believes this development represents a strong validation of Sarborg’s platform capabilities and its ability...

Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07, 2026 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of a long-distance cross-border telesurgery utilizing the SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) and spanning more than 4,500 miles from the surgeon located at the Royal Australian College of Surgeons in Perth, Australia to the patient in Indore,...

Final UPMC Primary Endpoint Report Details Positive Data from Ovarian Cancer Clinical Trial Combining Ampligen, Pembrolizumab and CisplatinRobert P. Edwards, MD, McCall Chair of Obstetrics, Gynecology, and Reproductive Science at the University of Pittsburgh School of MedicineRobert P. Edwards, MD, McCall Chair of Obstetrics, Gynecology, and Reproductive Science at the University of Pittsburgh School of MedicineOCALA, Fla., May 07, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the Final Primary Endpoint Report on Objective Response Rate data from a University of Pittsburgh Medical Center (“UPMC”) Phase 2 clinical trial – in which AIM and Merck Sharp & Dohme (“Merck”) are collaborators – evaluating Ampligen® (rintatolimod) in combination with checkpoint inhibition...

MONROE TOWNSHIP, N.J., May 07, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced progress in offshore charging and autonomous operations, supporting its industry leading strategy to enable longer-duration, lower-cost maritime missions. OPT has successfully demonstrated autonomous docking, charging, and redeployment of its maritime drone, the WAM-V® autonomous surface vehicle. The system allows a vehicle to approach a dock, secure itself, recharge, and return to operation without human intervention, in turn addressing a key limitation in offshore autonomy. The Company is advancing this capability for near-term integration with its PowerBuoy® platform, creating offshore...

LAS VEGAS, May 07, 2026 (GLOBE NEWSWIRE) — Starstream Entertainment Inc. today announced that it has officially completed its corporate name change to CityWalk e-Bike Inc. and will begin trading under its new ticker symbol OTCID:CWLK. The transition reflects the Company’s strategic repositioning toward next-generation mobility solutions, with a primary focus on electric and hydrogen-powered bike technologies. CityWalk e-Bike Inc. is actively advancing initiatives to transition its platform toward hydrogen-powered bike systems in China, targeting large-scale urban deployment opportunities and infrastructure partnerships. Management believes hydrogen-based mobility solutions may offer extended range, rapid refueling, and improved operational efficiency compared to traditional battery-powered alternatives, particularly in dense metropolitan...

MediWound to Report First Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 27th at 8:30 a.m. Eastern Time YAVNE, Israel, May 7, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 27, 2026. Following the release, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update. Conference Call & Webcast Details Toll-Free:                1-844-676-8833Israel:                     1-809-212373 International:          1-412-634-6869Webcast:                Click HERE To access the call, participants should dial the applicable...

LONDON, May 07, 2026 (GLOBE NEWSWIRE) — Diginex Limited (Nasdaq: DGNX) (“Diginex” or the “Company”), a provider of ESG, sustainability, and compliance solutions to institutional and corporate clients, today published an investor interview with Lorenzo Romano, Deputy Chairman of Diginex, addressing the Company’s newly unified strategy and its all‑share proposed acquisition of Resulticks Global Companies Pte Limited (“Resulticks”), a globally recognized leader in real‑time, AI‑driven customer intelligence solutions. When asked about the proposed Resulticks transaction and the thinking behind the acquisition, Romano stated, “The integration of Diginex’s high integrity data layer with Resulticks’ real time decisioning and orchestration capabilities enables enterprises to embed ESG signals directly into customer interactions, helping...

CHICAGO, May 07, 2026 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the first quarter and full year 2026. GCM Grosvenor issued a detailed presentation of its results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. The firm’s Board of Directors also approved a $0.12 per share dividend payable on June 15, 2026 to shareholders on record June 5, 2026. Conference Call A conference call to discuss GCM Grosvenor’s financial results will be held today, Thursday, May 7, 2026, at 10:00 a.m. ET. The call will be accessible via public webcast from the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events, and a replay of the live broadcast...